Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) Invested Capital (2020 - 2026)

PROCEPT BioRobotics has reported Invested Capital over the past 7 years, most recently at $399.3 million for Q1 2026.

  • Quarterly Invested Capital fell 9.38% to $399.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $399.3 million through Mar 2026, down 9.38% year-over-year, with the annual reading at $417.5 million for FY2025, 7.98% down from the prior year.
  • Invested Capital was $399.3 million for Q1 2026 at PROCEPT BioRobotics, down from $417.5 million in the prior quarter.
  • Over five years, Invested Capital peaked at $453.7 million in Q4 2024 and troughed at $207.2 million in Q2 2023.
  • The 5-year median for Invested Capital is $315.4 million (2024), against an average of $336.4 million.
  • Year-over-year, Invested Capital surged 256.3% in 2022 and then fell 28.48% in 2023.
  • A 5-year view of Invested Capital shows it stood at $248.3 million in 2022, then skyrocketed by 33.75% to $332.1 million in 2023, then soared by 36.62% to $453.7 million in 2024, then fell by 7.98% to $417.5 million in 2025, then fell by 4.35% to $399.3 million in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Invested Capital are $399.3 million (Q1 2026), $417.5 million (Q4 2025), and $431.8 million (Q3 2025).